Javascript must be enabled to continue!
Effect of Huthabhugadi Churna and Trayushnadi Ghrtam as an Ayurvedic Protocol in Metabolic Syndrome - A Case Series
View through CrossRef
The combination of obesity, dyslipidaemia, impaired glucose tolerance, hypertension often combined to the term ‘Metabolic Syndrome’ affects nowadays approximately more than 30% of the population of young generation. It has become a significant global health challenge associated with an increased risk of atherosclerotic cardiovascular disease (CVD). Ayurveda provides insights into the understanding of Metabolic Syndrome through concepts like Medodhatuvriddhi, Medovahasrothodushti, Santharpanajanya vikara (Sthoulya, Medoroga, Prameha, Hrdroga) and Amapradoshaja vikara. The aim of the study is to evaluate the efficacy of Huthabhugadi Churna and Trayushnadi Ghrtam as an Ayurvedic protocol in metabolic syndrome. This study is a case series done on 5 subjects, were Huthabhugadi Churna 6gm twice daily before food with Takra as Anupana was given for 14 days followed by Trayushnadi Ghrtam 5gm thrice daily with lukewarm water as Anupana next 14 days. Assessment was done on 0th day, 29th day and 42nd day with subjective and objective parameters. The Kapha vatahara and Medohara properties of trial drugs helped in the elimination of excess Medodhathu and formation of optimal Rasadi dhathus relieving the symptoms associated with metabolic syndrome The study showed a significant effect in normalising the lipid profile and improving the quality of life. These findings challenge the common misconception that consuming ghee leads to hyperlipidaemia offering valuable insights for further research and validation.
Title: Effect of Huthabhugadi Churna and Trayushnadi Ghrtam as an Ayurvedic Protocol in Metabolic Syndrome - A Case Series
Description:
The combination of obesity, dyslipidaemia, impaired glucose tolerance, hypertension often combined to the term ‘Metabolic Syndrome’ affects nowadays approximately more than 30% of the population of young generation.
It has become a significant global health challenge associated with an increased risk of atherosclerotic cardiovascular disease (CVD).
Ayurveda provides insights into the understanding of Metabolic Syndrome through concepts like Medodhatuvriddhi, Medovahasrothodushti, Santharpanajanya vikara (Sthoulya, Medoroga, Prameha, Hrdroga) and Amapradoshaja vikara.
The aim of the study is to evaluate the efficacy of Huthabhugadi Churna and Trayushnadi Ghrtam as an Ayurvedic protocol in metabolic syndrome.
This study is a case series done on 5 subjects, were Huthabhugadi Churna 6gm twice daily before food with Takra as Anupana was given for 14 days followed by Trayushnadi Ghrtam 5gm thrice daily with lukewarm water as Anupana next 14 days.
Assessment was done on 0th day, 29th day and 42nd day with subjective and objective parameters.
The Kapha vatahara and Medohara properties of trial drugs helped in the elimination of excess Medodhathu and formation of optimal Rasadi dhathus relieving the symptoms associated with metabolic syndrome The study showed a significant effect in normalising the lipid profile and improving the quality of life.
These findings challenge the common misconception that consuming ghee leads to hyperlipidaemia offering valuable insights for further research and validation.
Related Results
A Comprehensive Review on the Effect of an Ayurvedic Protocol in Metabolic Syndrome
A Comprehensive Review on the Effect of an Ayurvedic Protocol in Metabolic Syndrome
The clustering of obesity, dyslipidaemia, impaired glucose tolerance, and hypertension, known as 'Metabolic Syndrome (MS),' has emerged as a significant global public health and cl...
Pharmaceutical Standardization and Analytical Evaluation of different samples of Trayushnadi Gutika
Pharmaceutical Standardization and Analytical Evaluation of different samples of Trayushnadi Gutika
Introduction:Ayurvedic pharmaceutics (Rasashastra) emphasizes the purification and formulation of mineral- and metal-based drugs to enhance therapeutic efficacy and bioavailability...
Comparative Phytochemical and HPTLC Analysis of Nisha (Curcuma Longa Linn.) Chunra (powder), Amalaki (Phyllanthus emblica Linn.) Churna (Powder), and Nisha Amalaki Churna (Powder)
Comparative Phytochemical and HPTLC Analysis of Nisha (Curcuma Longa Linn.) Chunra (powder), Amalaki (Phyllanthus emblica Linn.) Churna (Powder), and Nisha Amalaki Churna (Powder)
Aim:
The aim of this study was to evaluate phytochemical constituent and high-performance thin-layer chromatography (HPTLC) analysis of Nisha churna, Amalaki churna, an...
A Pharmaceutical Study of Dadruhara Churna
A Pharmaceutical Study of Dadruhara Churna
Dadruhara Churna is a herbal formulation mentioned in the classical text called Siddha Bheshaja Manimala. It is a Dadru Hara Lepa, which contains Chakramarda beeja, Amalaki and Jee...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
The Effectiveness of Taalishadi Churna Compared with Sitopaladi Churna in the Management of Kasa
The Effectiveness of Taalishadi Churna Compared with Sitopaladi Churna in the Management of Kasa
Introduction: Kasa is a Vata-kapha pradhana disease, caused due to Vata vimargagaman and Pranavaha shrotodusti. Due to the various similarities in its clinical presentation, Kasa c...
The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome
The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome
SUMMARY OBJECTIVE: Patients with polycystic ovary syndrome face an increased risk of developing metabolic syndrome. Identifying biomarkers that can detect metabolic syndrome in po...
Determinants of Metabolic Syndrome among Malaysian Government Employees
Determinants of Metabolic Syndrome among Malaysian Government Employees
Introduction: The metabolic syndrome comprises a collection of cardiovascular disease risks, which has been demonstrated to predict type 2 diabetes mellitus and cardiovascular dise...

